Table 4

Epithelial defect diameter (mm) and epithelial defect area in the groups at various follow-up times

Day 0Day 3Day 7Day 14Day 21M1M2M3
Epithelial defect diameter (mm)
 CM (n=20)7.19±1.576.09±1.715.03±1.704.05±1.723.21±1.553.09±2.361.18±0.880.05±0.11
 UCS (n=17)6.91±2.334.48±2.222.47±1.501.48±0.930.76±0.470.43±0.500.08±0.150.00±0.00
 AMT (n=18)7.74±1.486.48±1.955.13±2.053.20±1.681.73±1.210.88±1.470.06±0.140.00±0.00
 p*0.7380.0690.0150.0010.0000.0040.0010.043
Epithelial defect area (mm2)
 CM (n=20)53.88±22.5939.72±19.7527.95±16.7312.50±10.416.01±5.222.39±2.510.01±0.040.01±0.01
 UCS (n=17)52.70±25.4724.60±15.988.11±7.821.03±1.130.47±0.720.02±0.050.00±0.000.00±0.00
 AMT (n=18)76.13±26.6845.54±27.0130.24±22.974.37±5.101.10±2.170.02±0.060.00±0.000.00±0.00
 p*0.0550.0590.0050.0000.0050.0010.0430.043
  • M1, 1 month follow-up; M2, 2 months follow-up; M3, 3 months follow-up; CM, conventional medical therapy; UCS, umbilical cord serum; AMT, amniotic membrane transplantation.

  • p*, p value comparison between the groups using Kruskal–Wallis test.